01—History
Total Liabilities & Equity History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $12.34B
2 older moves run past ±150% (largest +361.6%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is total liabilities & equity?
Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.
What is Moderna, Inc.'s current total liabilities & equity?
Moderna, Inc. (MRNA) annual total liabilities & equity for 2025 was $12.34B, a 12.76% decline from 2024. Moderna, Inc. total liabilities & equity for the quarter ending March 31, 2026 was $11.49B.
What was Moderna, Inc.'s total liabilities & equity in 2024?
Moderna, Inc. annual total liabilities & equity for 2024 was $14.14B, a 23.25% decline from 2023.
What was Moderna, Inc.'s total liabilities & equity in 2023?
Moderna, Inc. annual total liabilities & equity for 2023 was $18.43B, a 28.74% decline from 2022.
What is Moderna, Inc.'s 5-year total liabilities & equity CAGR?
Moderna, Inc. total liabilities & equity grew at a compound annual growth rate (CAGR) of 10.95% from FY2020 to FY2025, going from $7.34B to $12.34B over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)